SciVision Biotech Inc. | Cash Flow
Fiscal year is January-December. All values TWD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
31,364.00
22,145.00
46,772.00
31,129.00
22,670.00
93,100
Depreciation, Depletion & Amortization
22,712.00
19,138.00
19,845.00
21,232.00
20,937.00
20,633
Other Funds
20,000.00
42.00
-
42.00
-
3,811
Funds from Operations
53,034.00
6,609.00
68,607.00
10,082.00
42,115.00
117,544
Changes in Working Capital
14,669.00
11,937.00
18,355.00
46,895.00
25,699.00
7,774
Net Operating Cash Flow
38,365.00
5,328.00
50,252.00
36,813.00
16,416.00
109,770
Capital Expenditures
27,736.00
126,270.00
205,269.00
230,322.00
327,862.00
Sale of Fixed Assets & Businesses
448.00
-
285.00
-
-
Purchase/Sale of Investments
40,916.00
136,096.00
89,823.00
65,649.00
121,839.00
Net Investing Cash Flow
74,739.00
267,263.00
115,161.00
164,068.00
206,023.00
Cash Dividends Paid - Total
-
35,000.00
-
25,800.00
-
Issuance/Reduction of Debt, Net
1,090.00
3,476.00
26,018.00
285,757.00
186,577.00
Net Financing Cash Flow
606,710.00
38,434.00
99,788.00
259,915.00
186,577.00
Net Change in Cash
570,336.00
300,083.00
165,121.00
132,826.00
4,109.00
Free Cash Flow
11,508.00
120,431.00
154,255.00
187,769.00
307,744.00
Other Sources
-
-
-
605.00
-
Change in Capital Stock
627,800.00
-
125,806.00
-
-
Exchange Rate Effect
-
286.00
424.00
166.00
1,079.00
Other Uses
6,535.00
4,897.00
-
-
-
About SciVision Biotech
View Profile
